1.2400
29-April-25 16:45:00
15 minutes delayed
Stocks
+0.0300
+2.48%
Today's range
1.2100 - 1.3000
ISIN
N/A
Source
NASDAQ
PharmaCyte Biotech Board of Directors Announces Business Review Committee to Evaluate Opportunities to Optimize Shareholder Value
07 Oct 2022 09:00:00 By Nasdaq GlobeNewswire